Efficacy and Safety of Ciprofloxacin for Prophylaxis of Polyomavirus BK Virus-Associated Hemorrhagic Cystitis in Allogeneic Hematopoietic Stem Cell Transplantation Recipients

Biology of Blood and Marrow Transplantation

Volumn 17, Issue 8, 2011, Pages 1176-1181

  Miller, Ashley N ^a   Glode, Ashley ^b   Hogan, Kathy R ^b   Schaub, Christine ^a   Kramer, Cindy ^b   Stuart, Robert K ^a   Costa, Luciano J ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

BK virus; Ciprofloxacin; Cystitis; Opportunistic infections; Stem cell transplantation

Indexed keywords

BUSULFAN; CIPROFLOXACIN; MELPHALAN;

ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BACTEREMIA; BK VIRUS; CLOSTRIDIUM DIFFICILE; DEATH; DIARRHEA; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HEMORRHAGIC CYSTITIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MYELOABLATIVE CONDITIONING; POLYOMAVIRUS INFECTION; PROPHYLAXIS; RETROSPECTIVE STUDY; RISK FACTOR;

ADULT; AGED; ANTI-INFECTIVE AGENTS; BK VIRUS; CIPROFLOXACIN; CYSTITIS; FEMALE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; POLYOMAVIRUS INFECTIONS; RETROSPECTIVE STUDIES; TUMOR VIRUS INFECTIONS;

EID: 79960224473     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2010.12.700     Document Type: Article

References (28)

1. Leung A.Y., Suen C.K., Lie A.K., Liang R.H., Yuen K.Y., Kwong Y.L. Quantification of polyoma BK viruria in hemorrhagic cystitis complicating bone marrow transplantation. Blood 2001, 98:1971-1978.
2. Azzi A., Cesaro S., Laszlo D., et al. Human polyomavirus BK (BKV) load and haemorrhagic cystitis in bone marrow transplantation patients. J Clin Virol 1999, 14:79-86.
3. Silva Lde P., Patah P.A., Saliba R.M., et al. Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplants is the complex result of BK virus infection, preparative regimen intensity and donor type. Haematologica 2010, 95:1183-1190.
4. Gorczynska E., Turkiewicz D., Rybka K., et al. Incidence, clinical outcome, and management of virus-induced hemorrhagic cystitis in children and adolescents after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2005, 11:797-804.
5. Giraud G., Bogdanovic G., Priftakis P., et al. The incidence of hemorrhagic cystitis and BK-viruria in allogeneic hematopoietic stem cell recipients according to intensity of the conditioning regimen. Haematologica 2006, 91:401-404.
6. Bedi A., Miller C.B., Hanson J.L., et al. Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation. J Clin Oncol 1995, 13:1103-1109.
7. Leung A.Y., Mak R., Lie A.K., et al. Clinicopathological features and risk factors of clinically overt haemorrhagic cystitis complicating bone marrow transplantation. Bone Marrow Transplant 2002, 29:509-513.
8. Goudsmit J., Wertheim-van Dillen P., van Strien A., van der Noordaa J. The role of BK virus in acute respiratory tract disease and the presence of BKV DNA in tonsils. J Med Virol 1982, 10:91-99.
9. Hirsch H.H., Steiger J. Polyomavirus BK. Lancet Infect Dis 2003, 3:611-623.
10. Drummond J.E., Shah K.V., Saral R., Santos G.W., Donnenberg A.D. BK virus specific humoral and cell mediated immunity in allogeneic bone marrow transplant (BMT) recipients. J Med Virol 1987, 23:331-344.
11. Ost L., Lonnqvist B., Eriksson L., Ljungman P., Ringden O. Hemorrhagic cystitis-a manifestation of graft versus host disease?. Bone Marrow Transplant 1987, 2:19-25.
12. Leung A.Y., Yuen K.Y., Kwong Y.L. Polyoma BK virus and haemorrhagic cystitis in haematopoietic stem cell transplantation: a changing paradigm. Bone Marrow Transplant 2005, 36:929-937.
13. Erard V., Storer B., Corey L., et al. BK virus infection in hematopoietic stem cell transplant recipients: frequency, risk factors, and association with postengraftment hemorrhagic cystitis. Clin Infect Dis 2004, 39:1861-1865.
14. Leung A.Y., Chan M.T., Yuen K.Y., et al. Ciprofloxacin decreased polyoma BK virus load in patients who underwent allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 2005, 40:528-537.
15. Ferrazzi E., Peracchi M., Biasolo M.A., Faggionato O., Stefanelli S., Palu G. Antiviral activity of gyrase inhibitors norfloxacin, coumermycin A1 and nalidixic acid. Biochem Pharmacol 1988, 37:1885-1886.
16. Portolani M., Pietrosemoli P., Cermelli C., et al. Suppression of BK virus replication and cytopathic effect by inhibitors of prokaryotic DNA gyrase. Antiviral Res 1988, 9:205-218.
17. Giralt S., Ballen K., Rizzo D., et al. Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research. Biol Blood Marrow Transplant 2009, 15:367-369.
18. Rowlings P.A., Przepiorka D., Klein J.P., et al. IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade. Br J Haematol 1997, 97:855-864.
19. Dubberke E.R., Reske K.A., Srivastava A., et al. Clostridium difficile-associated disease in allogeneic hematopoietic stem-cell transplant recipients: risk associations, protective associations, and outcomes. Clin Transplant 2010, 24:192-198.
20. Therriault B.L., Wilson J.W., Barreto J.N., Estes L.L. Characterization of bacterial infections in allogeneic hematopoietic stem cell transplant recipients who received prophylactic levofloxacin with either penicillin or doxycycline. Mayo Clin Proc 2010, 85:711-718.
21. Gine E., Rovira M., Real I., et al. Successful treatment of severe hemorrhagic cystitis after hemopoietic cell transplantation by selective embolization of the vesical arteries. Bone Marrow Transplant 2003, 31:923-925.
22. Sebe P., Garderet L., Traxer O., Nouri M., Gluckman E., Gattegno B. Subtotal cystectomy with ileocystoplasty for severe hemorrhagic cystitis after bone marrow transplantation. Urology 2001, 57:168.
23. Gaziev J., Paba P., Miano R., et al. Late-onset hemorrhagic cystitis in children after hematopoietic stem cell transplantation for thalassemia and sickle cell anemia: a prospective evaluation of polyoma (BK) virus infection and treatment with cidofovir. Biol Blood Marrow Transplant 2010, 16:662-671.
24. Rao K.V., Buie L.W., Shea T., et al. Intravesicular cidofovir for the management of BK virus-associated cystitis. Biol Blood Marrow Transplant 2009, 15:391-392.
25. Ganguly N., Clough L.A., Dubois L.K., et al. Low-dose cidofovir in the treatment of symptomatic BK virus infection in patients undergoing allogeneic hematopoietic stem cell transplantation: a retrospective analysis of an algorithmic approach. Transpl Infect Dis 2010, [Epub ahead of print].
26. Savona M.R., Newton D., Frame D., Levine J.E., Mineishi S., Kaul D.R. Low-dose cidofovir treatment of BK virus-associated hemorrhagic cystitis in recipients of hematopoietic stem cell transplant. Bone Marrow Transplant 2007, 39:783-787.
27. Gabardi S., Waikar S.S., Martin S., et al. Evaluation of fluoroquinolones for the prevention of BK viremia after renal transplantation. Clin J Am Soc Nephrol 2010, 5:1298-1304.
28. Bland J.M., Altman D.G. Some examples of regression towards the mean. BMJ 1994, 309:780.